Registry of Lobbyists
Subject matters | Details | Categories |
---|---|---|
Economic Development,
Industry,
International Trade
|
Communications regarding Canada’s engagement in international trade agreements in particular Comprehensive and Economic Trade Agreement (CETA) and North American Free Trade Agreement (NAFTA) and any other agreements as it relates to any aspects which affect the local business environment for J&J Inc.
|
Policies or Program
|
Consumer Issues,
Economic Development,
Health,
Industry
|
Communications regarding Health Canada’s multi-year Regulatory Modernization initiative to modernize the Food and Drug Act and Regulations, specifically with respect to approval, regulation and life cycle management of consumer products.
|
Policies or Program,
Regulation
|
Consumer Issues,
Economic Development,
Industry,
Internal Trade,
International Trade
|
Communications regarding maintenance of domestic supply of essential consumer products, including in relation to the Drug Shortages Task Force.
|
Policies or Program
|
Health,
Industry
|
Communications regarding regulations relating to labelling and product monographs.
|
Regulation
|
Consumer Issues,
Health,
Industry
|
Communications regarding the Chemicals Management Plan as related to the regulation of chemical substances, particularly as affecting ingredients used in consumer health products.
|
Policies or Program
|
Consumer Issues,
Health
|
Communications regarding the development of federally funded programs or other policies to reach the Canadian government’s stated goal of 5% tobacco usage by 2035.
|
Policies or Program
|
Consumer Issues,
Health,
Industry
|
Communications regarding the retail manufacturing code of conduct for food and health products and the grocery code of conduct.
|
Policies or Program
|
Economic Development,
Health,
Industry
|
Local manufacturing of healthcare products – Regarding the development of policies and programs (including funding programs) to support the expansion of existing manufacturing facilities or the establishment of additional manufacturing capacity in Canada.
|
Policies or Program
|
Consumer Issues,
Health
|
Self-care – Regarding the development of policies and programs to support self-care, and safe use of consumer health products.
|
Policies or Program
|
Climate,
Environment,
Industry
|
Zero plastic waste by 2030 – Regarding legislative proposals regulating plastic packaging and implementing plastic waste management programs.
|
Legislative Proposal, Bill or Resolution
|
Subject matters | Details | Categories |
---|---|---|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
COVID-19: Regarding the development of policies and programs to address the COVID-19 pandemic and support the re-opening of the Canadian economy, including as it relates to tackling health equity across marginalized communities in Canada and surgical backlogs.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Canada’s engagement and leadership on programs and policies relating to mental health both domestic and international
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Canada’s engagement in international trade agreements in particular Comprehensive and Economic Trade Agreement (CETA) and North American Free Trade Agreement (NAFTA) and any other agreements as it relates to intellectual property considerations and other aspects which affect the local business environment for J&J companies
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Canada’s partnerships on global health and global community impact with Johnson & Johnson relating to maternal and child health, First Nations, mental health and other areas
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Changes to NAFTA to address United States-Mexico-Canada Agreement (USMCA) relevant for life sciences sector
|
Legislative Proposal, Bill or Resolution
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Chemical Management Plan as related to the regulation of chemical substances, particularly as affecting ingredients used in therapeutic products
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Communiation to officials regarding the Regulatory Cooperation council.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Communication regarding the review by the Health Committee on regulation of e-cigarettes.
|
Legislative Proposal, Bill or Resolution
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Communication to officials on labelling and product monographs.
|
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Communication to officials regarding Look Alike Sound Alike Guidance communication.
|
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Communications regarding Canada’s engagement in international trade agreements in particular Comprehensive and Economic Trade Agreement (CETA) and North American Free Trade Agreement (NAFTA) and any other agreements as it relates to any aspects which affect the local business environment for J&J Inc.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Communications regarding Health Canada’s multi-year Regulatory Modernization initiative to modernize the Food and Drug Act and Regulations, specifically with respect to approval, regulation and life cycle management of consumer products.
|
Policies or Program,
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Communications regarding maintenance of domestic supply of essential consumer products, including in relation to the Drug Shortages Task Force.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Communications regarding maintenance of domestic supply of essential consumer products.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Communications regarding regulations relating to labelling and product monographs.
|
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Communications regarding the Chemicals Management Plan as related to the regulation of chemical substances, particularly as affecting ingredients used in consumer health products.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Communications regarding the development of federally funded programs or other policies to reach the Canadian government’s stated goal of 5% tobacco usage by 2035.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Communications regarding the retail manufacturing code of conduct for food and health products and the grocery code of conduct.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Communications regarding the retail manufacturing code of conduct for food and health products.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Engagement on government’s Innovation Agenda as it relates to Health and Bio Sciences sector
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Engaging government on issues relating to the potential implementation of National Pharmacare
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Evolution of role and mandate of drug pricing regime in Canada
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Food and Drug Act: Delays in product approvals and changes to existing products
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Food and Drug Regulation: Nonprescription drugs labelling standards - Drug Products: Draft Guidance Document: Nonprescription Oral Pediatric Cough and Cold Labelling Standard,participated in Health Canada's consultation process
|
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Health Canada’s multi-year Regulatory Modernization initiative to modernize the Food and Drug Act and Regulations, specifically with respect to approval, regulation and life cycle management of therapeutic products
|
Policies or Program,
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Local manufacturing of healthcare products – Regarding the development of policies and programs (including funding programs) to support the expansion of existing manufacturing facilities or the establishment of additional manufacturing capacity in Canada.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Modernizations of the Food and Drugs Act, with respect to inspection, reporting and confidential business information
|
Regulation
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Self-care – Regarding the development of policies and programs to support self-care, and safe use of consumer health products.
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Self-care – Regarding the development of policies and programs to support self-care, including tax incentives for self-care products that have an impact on health (for e.g. sunscreen, smoking cessation).
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Smoking cessation – Regarding the development of federally funded programs or other policies to facilitate smoking cessation (for e.g. tobacco tax).
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Treasury Board initiative to address international regulatory cooperation as well as their work on the Canada US, and Canada EU Regulatory Cooperation Councils
|
Policies or Program
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Zero plastic waste by 2030 – Regarding legislative proposals regulating plastic packaging and implementing plastic waste management programs.
|
Legislative Proposal, Bill or Resolution
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
Zero plastic waste by 2030 – Regarding potential legislative proposal regulating harmful single-use plastic items and implementing plastic waste management programs.
|
Legislative Proposal, Bill or Resolution
|
Subject matters were not required to be associated with subject matter details when this content was submitted
|
any regulatory changes that may emerge relating to the policy areas identified above including Health Canada Modernization efforts, Patented Medicine Prices Review Board (PMPRB), Treasury Board Initiative on international regulatory cooperation
|
Regulation
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Date | DPOH, Position Title | Government Institution | Subject Matters |
---|---|---|
2024-02-09 |
|
Consumer Issues, Health, Industry |
2024-01-24 |
|
Consumer Issues, Health, Industry |
2023-12-04 |
|
Consumer Issues, Health, Industry |
2023-11-02 |
|
Consumer Issues, Health, Industry |